Dashboard
Manage Tickers

RVNC Revance Therapeutics, Inc.

Nasdaq revance.com


$ 0.01 (0.27 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.38 $ -6.82 (-1.13 %)
DIA $ 459.60 $ -3.77 (-0.81 %)
SPY $ 659.76 $ -7.13 (-1.07 %)
TLT $ 91.35 $ 0.85 (0.93 %)
GLD $ 394.62 $ 3.47 (0.89 %)
$ 3.65
-- x --
-- x --
-- - --
$ 2.30 - $ 7.56
4,123,191
na
382.89M
$ 1.34
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2024 09-30-2024 10-Q
2 08-08-2024 06-30-2024 10-Q
3 05-09-2024 03-31-2024 10-Q
4 02-28-2024 12-31-2023 10-K
5 11-08-2023 09-30-2023 10-Q
6 08-08-2023 06-30-2023 10-Q
7 05-09-2023 03-31-2023 10-Q
8 02-28-2023 12-31-2022 10-K
9 11-08-2022 09-30-2022 10-Q
10 08-09-2022 06-30-2022 10-Q
11 05-10-2022 03-31-2022 10-Q
12 02-28-2022 12-31-2021 10-K
13 11-09-2021 09-30-2021 10-Q
14 08-05-2021 06-30-2021 10-Q
15 05-10-2021 03-31-2021 10-Q
16 02-25-2021 12-31-2020 10-K
17 11-09-2020 09-30-2020 10-Q
18 08-06-2020 06-30-2020 10-Q
19 05-07-2020 03-31-2020 10-Q
20 02-26-2020 12-31-2019 10-K
21 11-04-2019 09-30-2019 10-Q
22 08-06-2019 06-30-2019 10-Q
23 05-09-2019 03-31-2019 10-Q
24 02-28-2019 12-31-2018 10-K
25 11-02-2018 09-30-2018 10-Q
26 08-03-2018 06-30-2018 10-Q
27 05-09-2018 03-31-2018 10-Q
28 03-02-2018 12-31-2017 10-K
29 11-03-2017 09-30-2017 10-Q
30 08-04-2017 06-30-2017 10-Q
31 05-09-2017 03-31-2017 10-Q
32 02-28-2017 12-31-2016 10-K
33 11-04-2016 09-30-2016 10-Q
34 08-05-2016 06-30-2016 10-Q
35 05-10-2016 03-31-2016 10-Q
36 03-04-2016 12-31-2015 10-K
37 11-10-2015 09-30-2015 10-Q
38 08-07-2015 06-30-2015 10-Q
39 05-14-2015 03-31-2015 10-Q
40 03-04-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

crown-laboratories-and-revance-amend-the-ar-merger-agreement-to-increase-offer-price-to-365-per-share-a-055-per-share-increase-and-extend-existing-tender-offer
Crown Laboratories And Revance Amend The A...
01/21/2025 13:06:44

Increased offer price to $3.65 per share, a $0.55 per share increaseImproved offer unanimously approved by Revance Board of Dir...

deal-dispatch-biden-punts-tiktok-ban-to-trump-plus-another-legacy-retailer-goes-bankrupt
Deal Dispatch: Biden Punts TikTok Ban To T...
01/17/2025 19:58:53

Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charlesto...

needham-reiterates-hold-on-revance-therapeuticsto-hold
Needham Reiterates Hold on Revance Therape...
01/17/2025 17:37:52

Needham analyst Serge Belanger reiterates Revance Therapeutics (NASDAQ:RVNC) from Hold to Hold.

crown-laboratories-extension-of-tender-offer-to-acquire-revance-therapeutics-inc-at-a-price-of-310-per-share-in-cash
Crown Laboratories Extension Of Tender Off...
01/13/2025 14:03:26

Crown Laboratories, Inc. ("Crown"), a privately held, global innovative leader in the skincare industry, today announce...

teoxane-sa-submits-proposal-to-acquire-revance-for-360-per-share-in-cash-proposal-represents-premium-over-310-agreement-with-crown-laboratories
Teoxane SA Submits Proposal To Acquire Rev...
01/06/2025 14:07:09

barclays-maintains-equal-weight-on-revance-therapeutics-lowers-price-target-to-3
Barclays Maintains Equal-Weight on Revance...
12/23/2024 12:43:24

Barclays analyst Balaji Prasad maintains Revance Therapeutics (NASDAQ:RVNC) with a Equal-Weight and lowers the price target ...

crown-laboratories-announces-that-it-has-commenced-a-cash-tender-offer-to-acquire-all-outstanding-shares-of-common-stock-of-revance-therapeutics-at-a-price-of-310-per-share-in-cash
Crown Laboratories Announces That It Has C...
12/12/2024 13:17:00

Board of Directors of Revance Recommend Stockholders Tender their SharesJOHNSON CITY, Tenn., Dec. 12, 2024 /PRNewswire/ -- Crow...

mizuho-maintains-neutral-on-revance-therapeutics-lowers-price-target-to-31
Mizuho Maintains Neutral on Revance Therap...
12/10/2024 13:09:16

Mizuho analyst Vamil Divan maintains Revance Therapeutics (NASDAQ:RVNC) with a Neutral and lowers the price target from $6.6...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
12/09/2024 21:05:43

crown-laboratories-and-revance-enter-amended-and-restated-merger-agreement-under-terms-of-amended-and-restated-agreement-crown-will-commence-tender-offer-to-acquire-all-outstanding-shares-of-revances-common-stock-for-310-per-share-in-cash
Crown Laboratories And Revance Enter Amend...
12/09/2024 13:35:09

revance-therapeutics-extends-tender-offer-deadline-with-crown-laboratories-and-reba-merger-sub-to-december-9-amid-ongoing-discussions-with-potential-for-further-delays-or-modifications-to-merger-agreement-terms-including-offer-price-adjustments
Revance Therapeutics Extends Tender Offer ...
12/05/2024 21:52:03

revance-therapeutics-extends-tender-offer-deadline-for-merger-with-crown-laboratories-to-december-3-2024-amid-ongoing-discussions
Revance Therapeutics Extends Tender Offer ...
11/29/2024 11:25:16

-Filing

tyson-foods-posts-better-than-expected-earnings-joins-shopify-sea-buckle-and-other-big-stocks-moving-higher-on-tuesday
Tyson Foods Posts Better-Than-Expected Ear...
11/12/2024 19:27:03

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
11/08/2024 21:06:27

needham-reiterates-hold-on-revance-therapeutics
Needham Reiterates Hold on Revance Therape...
11/08/2024 18:24:20

Needham analyst Serge Belanger reiterates Revance Therapeutics (NASDAQ:RVNC) with a Hold.

hc-wainwright--co-reiterates-neutral-on-revance-therapeutics-maintains-66-price-target
HC Wainwright & Co. Reiterates Neutral on ...
11/08/2024 16:35:18

HC Wainwright & Co. analyst Douglas Tsao reiterates Revance Therapeutics (NASDAQ:RVNC) with a Neutral and maintains $6.6...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
11/08/2024 16:32:01

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
11/08/2024 12:05:44

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
11/08/2024 12:05:44

revance-therapeutics-q3-eps-037-beats-038-estimate-sales-5988m-miss-6820m-estimate
Revance Therapeutics Q3 EPS $(0.37) Beats ...
11/07/2024 22:22:46

Revance Therapeutics (NASDAQ:RVNC) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION